Gherardi, R K · Revue neurologique · 2003
This review examines macrophagic myofasciitis, a condition where aluminum from vaccine adjuvants persists in muscle tissue and may trigger long-lasting immune activation. About half of patients develop fatigue and muscle pain that meet ME/CFS criteria, and some develop autoimmune diseases. The authors suggest that persistent immune stimulation from the aluminum depot could explain both this vaccine-related condition and possibly other forms of ME/CFS.
This work identifies a plausible immunologic mechanism—persistent aluminum adjuvant-driven Th-2 immune activation—that may explain ME/CFS in a defined subset of patients and offers a framework for investigating similar mechanisms in idiopathic and post-infectious ME/CFS. Understanding vaccine adjuvant-related immune dysregulation could inform both diagnosis and development of safer adjuvant formulations, while validating immune dysfunction as central to ME/CFS pathophysiology.
This review does not prove that aluminum adjuvants cause the majority of ME/CFS cases, nor does it establish causality for idiopathic ME/CFS—it proposes a mechanism in a subset of patients with demonstrable focal lesions. The study does not quantify the prevalence of macrophagic myofasciitis in the general or ME/CFS population, nor does it confirm that all MMF patients progress to systemic illness. Correlation between aluminum persistence and symptoms does not rule out other contributing factors or genetic predispositions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Gherardi, R K (2003). [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].. Revue neurologique. https://pubmed.ncbi.nlm.nih.gov/12660567/
BibTeX
@article{mecfsatlas-gherardi-2003-lessons-macrophagic,
author = {Gherardi, R K},
title = {[Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].},
journal = {Revue neurologique},
year = {2003},
note = {PubMed: 12660567},
url = {https://www.mecfsatlas.com/evidence/gherardi-2003-lessons-macrophagic},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-26. https://www.mecfsatlas.com/evidence/gherardi-2003-lessons-macrophagic
Contribute
Private, reviewed by a human. Not a public comment thread.